Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.
about
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cellsChallenges to the clinical application of pluripotent stem cells: towards genomic and functional stabilityGrowth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitorsGeneration and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade statusDirect reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vesselsHeart regenerationTargeting serous epithelial ovarian cancer with designer zinc finger transcription factorsWidespread occurrence of 5-methylcytosine in human coding and non-coding RNABright and stable near-infrared fluorescent protein for in vivo imagingGeneration of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in miceInduced Pluripotent Stem (iPS) Cells in Dentistry: A ReviewA Broad Overview and Review of CRISPR-Cas Technology and Stem Cellsβ-Cell regeneration through the transdifferentiation of pancreatic cells: Pancreatic progenitor cells in the pancreasModeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future ConcernsA Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future ProspectsTranslating the epitranscriptomeInduced Pluripotent Stem Cell Therapies for Cervical Spinal Cord InjuryHuman induced pluripotent stem cells for monogenic disease modelling and therapyhiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineDissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotencyBiomedical Application of Dental Tissue-Derived Induced Pluripotent Stem CellsThe Importance of Ubiquitination and Deubiquitination in Cellular ReprogrammingThe Progress of Induced Pluripotent Stem Cells as Models of Parkinson's DiseaseThe Use of Stem Cells to Model Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: From Basic Research to Regenerative MedicineRecent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem CellsCellular reprogramming in farm animals: an overview of iPSC generation in the mammalian farm animal speciesReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementPluripotent Stem Cells: Current Understanding and Future DirectionsInduced Pluripotency and Gene Editing in Disease Modelling: Perspectives and ChallengesAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsStem cell-based regenerative opportunities for the liver: State of the art and beyondInduced Pluripotent Stem Cells and Periodontal RegenerationStem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver InjuryUnderstanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patientsMesenchymal and induced pluripotent stem cells: general insights and clinical perspectivesResearch on induced pluripotent stem cells and the application in ocular tissuesCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsApplications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative DiseasesPatient-Specific iPSC-Derived RPE for Modeling of Retinal Diseases
P2860
Q54796927-8418FBB9-1AF7-4F22-B0EB-1D793E3F3CCEQ54796928-6F421EC5-EB67-4F40-AFF2-53B96654BB4EQ54796964-E2E82A1E-FF94-499F-AFB1-93D5EEFFC44BQ54811353-3838A012-EF76-40BE-A44B-4BD265D0B85BQ54811354-65F8D4FB-9AE2-4908-ABF1-A40A3F31296BQ54811355-D0D3A3C4-FECD-4167-9E37-06536EEA40A1Q54817243-4B6F49C9-C588-4234-8CFC-D0CA01C70BDBQ54817244-4161E62B-C8DD-4CDA-BFE4-85C47C7584B5Q54817245-65936734-A6BD-4774-A4E9-CBB339FB5B03Q54831055-234F34C9-D90D-4097-BE41-5678E955029EQ54831056-70193292-31BB-4095-9441-B776C7BFDF6DQ54831057-CA5FB667-5B70-4872-A69F-F63C85FDBB66Q54831058-429B7F2F-5265-42DC-9845-2AC37DC558BCQ54831059-640CC73F-3DC6-4A17-B355-6FFF808C36B9Q54831060-1CDF955C-1E39-4B5D-A903-8E36E4C78D93Q54831061-3A4A53CC-72CF-4D44-87BA-41CC2BEB2790Q54831063-7198C6D4-6F06-4A3E-A7CE-782DEBBB17BCQ54906727-E6991B44-CBB0-45F0-A384-87A12322BF65Q54906728-F3D1711C-FA56-4E9E-9A10-16FF7CE9E2ABQ54906729-C29D55E8-823B-43F9-A105-9831C07F9FA6Q54906730-2B286433-E10B-442F-B7B4-8515C179DF07Q54906731-7FF8F6DB-469A-4FCB-81E3-7F187DD5418F
P1343
Q21134034-5652501F-A39A-4CCB-904B-EC51670BFEB2Q21183968-65AC17C9-6CD3-414B-AC2F-B87AAC2A98F1Q21560773-DBD0F430-4F29-4BC3-9321-268FB93CD49EQ21999273-AB9EB268-2492-490C-8EB7-ABA75A887ECDQ24295157-B9D27E9E-BD33-4FB9-86BD-D4B444D49477Q24562846-A7351B9B-DD1C-4766-A384-13B99923C970Q24605597-CC787B09-6324-40C4-B1B9-48A68AD24A55Q24611983-5654B20F-1561-47B6-9859-3EEF1ACDC44AQ24621011-5DE51FA8-EBCA-4622-BB34-898DAA86E5EDQ24631565-D68F2B06-0965-4D7C-A589-A00B9976E2C7Q24635187-BDC11A5D-580B-4D50-A445-4A2AAC731FC7Q26738393-B7207DF3-C350-462D-A2FA-600C9415982BQ26741371-4CAFA7FE-64F2-460A-B864-5259216F7251Q26743633-10E66378-C4F0-4DBF-8816-B3A52A2BC1A6Q26745513-8F58A973-49D0-421B-B333-4C1359D07411Q26746033-B1611262-33EF-4E23-96BE-4792531869B5Q26747114-C78069CC-478D-4308-B91D-F02750609D61Q26748907-E8A5D169-B352-4C9D-9026-1FB63C0B1DD3Q26750393-3B8D6E15-909A-44D3-BDB0-C00904375B12Q26751506-34DBB003-2D7D-455D-AE7B-F4B4A4E2BE0DQ26752448-0EA979B3-CF55-4275-883F-E2019FA782FDQ26753857-AC49EB8B-0284-41B9-8C06-28B6D3E0A578Q26765873-60E68708-A9EA-448B-AC1A-A0C1068F912EQ26765894-3EC11D9A-156B-4434-A645-15B9670E05B6Q26766372-7E0E2909-BC8F-4FD4-A509-E7A7AFF8F05AQ26767096-026EF7DF-D560-410A-B60C-9C496C30E57BQ26768505-7187AE30-B390-4E91-AAC1-9EDCE3DAC5BBQ26769878-83836FBF-8A91-4ED8-9C8E-D04336734F8FQ26769981-321EB727-407C-4F97-B38C-5801773206ACQ26775061-CD750564-65FD-474F-9FE1-CB172B8B79FFQ26775122-306C0193-4DEA-43A4-90B4-B649246F67C9Q26775924-1BE7BBB8-F61C-45E8-8933-A4CAF359972AQ26777488-97F5E3A1-2D17-4DEA-8031-D2187707393AQ26781923-C6169A90-6D1C-4519-8730-6A4291980B4EQ26784399-37C3DA14-CA62-46B7-A4FB-0325FD8ECFD3Q26785623-933661AC-FED8-47CA-9343-3818CFE0AA0EQ26796711-095C4429-ABB2-46B0-8979-F1F076A367CBQ26798131-23C75B4A-142D-48EC-AF83-DC2CD2983421Q26799331-4E1EA697-F9AB-43C1-ABA6-7752AF3988E2Q26799586-13773BFC-1A15-4641-BBA7-DC62F95CA4A3
P2860
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Highly efficient reprogramming ...... s with synthetic modified mRNA
@nl
Highly efficient reprogramming ...... with synthetic modified mRNA.
@ast
Highly efficient reprogramming ...... with synthetic modified mRNA.
@en
type
label
Highly efficient reprogramming ...... s with synthetic modified mRNA
@nl
Highly efficient reprogramming ...... with synthetic modified mRNA.
@ast
Highly efficient reprogramming ...... with synthetic modified mRNA.
@en
altLabel
Highly efficient reprogramming ...... s with synthetic modified mRNA
@en
prefLabel
Highly efficient reprogramming ...... s with synthetic modified mRNA
@nl
Highly efficient reprogramming ...... with synthetic modified mRNA.
@ast
Highly efficient reprogramming ...... with synthetic modified mRNA.
@en
P2093
P2860
P4510
P3181
P1433
P1476
Highly efficient reprogramming ...... with synthetic modified mRNA.
@en
P2093
Andrew S Brack
Chad Cowan
Derrick J Rossi
James J Collins
Luigi Warren
Pankaj K Mandal
Philip D Manos
Thorsten M Schlaeger
P2860
P304
P3181
P356
10.1016/J.STEM.2010.08.012
P407
P4510
P577
2010-09-30T00:00:00Z